Chrousos Phaedra 4
4 · Vanda Pharmaceuticals Inc. · Filed Jun 17, 2019
Insider Transaction Report
Form 4
Chrousos Phaedra
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-13+10,000→ 10,000 totalExercise: $15.04Exp: 2029-06-12→ Common Stock (10,000 underlying) - Award
Common Stock
2019-06-13+5,000→ 5,000 total
Footnotes (2)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.
- [F2]This option vests and becomes exercisable with respect to 100% of the option shares on June 13, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.